Gene therapy for rheumatoid arthritis

  title={Gene therapy for rheumatoid arthritis},
  author={A. Reinhardt and R. Hirsch},
  journal={Future Rheumatology},
  • A. Reinhardt, R. Hirsch
  • Published 2007
  • Medicine
  • Future Rheumatology
  • Therapy for rheumatoid arthritis (RA) has seen significant advances over the past decade. The use of biologic agents, such as TNF-α inhibitors, have led to improvement in up to 60% of RA patients. Unfortunately, biologic therapy also presents significant limitations, including systemic side effects, a short half-life with requirement for frequent dosing, and a lack of curative response. Owing to such limitations, the ideal therapy for RA remains unrealized. Progress in the field of gene therapy… CONTINUE READING
    1 Citations

    Figures, Tables, and Topics from this paper.

    Explore Further: Topics Discussed in This Paper


    Application of cellular gene therapy for rheumatoid arthritis
    • 17
    • PDF
    Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.
    • 1,121
    • PDF
    Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.
    • 2,306
    • PDF
    Gene transfer to human joints: progress toward a gene therapy of arthritis.
    • 193
    • Highly Influential
    • PDF
    Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4
    • 13
    Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy.
    • 192
    • Highly Influential
    Chemokines and their receptors in rheumatoid arthritis: future targets?
    • A. Koch
    • Medicine
    • Arthritis and rheumatism
    • 2005
    • 225